[Lymphoblastic non-Hodgkin's lymphoma: estimation of the survival of patients with the disseminated form of the disease (stages III and IV) treated by the LSA2-L2 protocol].

Abstract

We analyze the survival rate in 17 pediatric patients (twelve males and five females) that were diagnoses of non-Hodgkin's lymphoblastic lymphoma (cases with Burkitt's lymphoma were excluded) during the period from 1982 to 1990. All of them were treated using the LSA2-L2 therapeutic protocol. The follow-up period ranged from 14 to 99 months (follow-up median 43 months). Staging of our newly diagnosed patients, we found 9 patients in stage III and 8 in stage IV disease. Survival was analyzed by the Kaplan-Meier method. The overall survival rate of our patients is 69.5% and the disease free survival is 62.6%. The disease free survival for separated stages is 66.5% for stage III and 58.3% for stage IV. We compare our results with other casuisties published in literature.

• Authors: J Pisón Garcés, J C Buñuel Alvarez, M P Domínguez Fenollé, J A Castillo Laita, T Cenarro Guerrero, M J Monreal Gálvez, T Arana Navarro, A Hernández Gayá
• Journal: Anales espanoles de pediatria (An Esp Pediatr) Vol. 35 Issue 6 Pg. 381-4 (Dec 1991) ISSN: 0302-4342 [Print] Spain
• Vernacular Title: Linfoma no Hodgkin de tipo linfoblástico: evaluación de la supervivencia en pacientes con enfermedad diseminada (estadío III y IV) tratados con el protocolo LSA2-L2.
• PMID: 1793185 (Publication Type: English Abstract, Journal Article)

Topics

• Child
• Clinical Protocols
• Female
• Humans
• Lymphoma, Non-Hodgkin (mortality, pathology, therapy)
• Male
• Precursor Cell Lymphoblastic Leukemia-Lymphoma (mortality, pathology, therapy)
• Prognosis
• Spain (epidemiology)
• Survival Rate